MX9706361A - Sales de carboxiamidas estables, de accion prolongada, composiciones que las contienen y el uso de las mismas. - Google Patents
Sales de carboxiamidas estables, de accion prolongada, composiciones que las contienen y el uso de las mismas.Info
- Publication number
- MX9706361A MX9706361A MX9706361A MX9706361A MX9706361A MX 9706361 A MX9706361 A MX 9706361A MX 9706361 A MX9706361 A MX 9706361A MX 9706361 A MX9706361 A MX 9706361A MX 9706361 A MX9706361 A MX 9706361A
- Authority
- MX
- Mexico
- Prior art keywords
- carboxamides
- treatment
- joint disease
- long acting
- stable long
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Indole Compounds (AREA)
Abstract
Las sales de calcio, magnesio, lidocaina y benzatina de 2-oxiindol-1-carboxiamida son utiles para el tratamiento de la enfermedad de articulacion mediante administracion intraarticular.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2424796P | 1996-08-21 | 1996-08-21 | |
| US024247 | 1996-08-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9706361A true MX9706361A (es) | 1998-07-31 |
| MXPA97006361A MXPA97006361A (es) | 1998-11-09 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| CA2213361A1 (en) | 1998-02-21 |
| EP0826685A1 (en) | 1998-03-04 |
| BR9704476A (pt) | 1998-12-29 |
| JPH1087614A (ja) | 1998-04-07 |
| US5968969A (en) | 1999-10-19 |
| JP2961093B2 (ja) | 1999-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
| EP1870103A3 (en) | Use of uridine in combination with choline for the treatment of memory disorders | |
| IL130931A0 (en) | Small molecules useful in the treatment of inflammatory disease | |
| AU5624699A (en) | Use of 5ht-6 antagonists | |
| EE9900539A (et) | Uued ühendid | |
| FI956014A (fi) | Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon | |
| ZA9710796B (en) | Oxyiminopregnanecarbolactones. | |
| BG102726A (en) | Combined therapy for osteoporosis | |
| ZA965752B (en) | Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents. | |
| FI972308A (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
| AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
| BG103714A (en) | Pararacetamol-containing tablet | |
| ATE239474T1 (de) | Verwendung von levobupivacain | |
| ZA973622B (en) | Use of forms of hyaluronic acid (HA) for the treatment of cancer. | |
| DE69120287D1 (en) | Aminosulfonylharnstoff-acat-inhibitoren | |
| BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
| MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
| CA2296560A1 (en) | Amino acid derivatives useful to treat stroke | |
| HK1002658A1 (en) | Imidazopyridine-azolidinones their preparation and pharmaceutical use | |
| MX9706361A (es) | Sales de carboxiamidas estables, de accion prolongada, composiciones que las contienen y el uso de las mismas. | |
| EP1083914A4 (en) | TREATING ARTHRITIS AND OTHER SIMILAR DISORDERS | |
| DE69930952D1 (de) | Gesteuerte freisetzung von antidepressiva | |
| ID21968A (id) | Turunan-turunan 11-asetil-12, 13-dioksabisiklo (8.2.1)-tridesenon, proses pembuatannya dan senyawa yang digunakan sebagai obat | |
| JP2002511904A5 (es) | ||
| MD980129A (en) | Antiherpetic remedy |